NCT04912024View on ClinicalTrials.gov

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study

CompletedOBSERVATIONAL
Enrollment

458

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

June 15, 2022

Conditions
End Stage Kidney DiseaseEnd Stage Renal DiseaseAcute Kidney Injury
Interventions
DEVICE

Intermittent Renal Replacement Therapy using the Tablo Hemodialysis System

Intermittent renal replacement therapy using the Tablo Hemodialysis System in the acute setting for participants with AKI or ESKD

DEVICE

Intermittent Renal Replacement Therapy using Conventional Hemodialysis Systems

Intermittent renal replacement therapy using Conventional Hemodialysis Systems in the acute setting for participants with AKI or ESKD

Trial Locations (2)

32803

Adventist Health System, Orlando

76104

Texas Health Harris Methodist Hospital Fort Worth, Fort Worth

Sponsors

Lead Sponsor

Outset Medical
All Listed Sponsors
lead

Outset Medical

INDUSTRY